> top > projects > UCDIT_TEST > docs > sourcedb > PubMed
UCDIT_TEST  

Documents (9,995) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PubMed 34259316 Retardant effect of dihydroartemisinin on ulcerative colitis in a JAK2/STAT3-dependent manner. Dihydroartemisinin (DHA) is a semi-synthetic derivative and the main active metabolite of artemisinin. Th 1.93 KB 2022-05-31 2 2022-11-11
PubMed 19035968 Plasma lipids and inflammation in active inflammatory bowel diseases. BACKGROUND: Ulcerative colitis (UC) and Crohn's disease (CD) can cause metabolic and inflammatory alterations. AIM: To evaluate th 1.39 KB 2022-05-31 2 2022-11-11
PubMed 34298022 Systemic Inflammation in Preclinical Ulcerative Colitis. BACKGROUND & AIMS: Preclinical ulcerative colitis is poorly defined. We aimed to characterize the preclinical systemic inflammation in ulcerati 2.02 KB 2022-05-31 2 2022-11-11
PubMed 34485904 Telenutrition for Inflammatory Bowel Disease: A Tipping Point for Dietary Wellness. Inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, cause inflammation of the digestive tract. 886 Bytes 2022-05-31 2 2022-11-11
PubMed 27110920 The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity. BACKGROUND: A large proportion (25 2.1 KB 2017-09-04 4 2022-11-11
PubMed 17072956 Impact of lipoprotein lipase gene polymorphisms on ulcerative colitis. AIM: To examine the influence of lipoprotein lipase (LPL) gene polymorphism in ulcerative colitis (UC) patients. METHODS: Periphe 1.61 KB 2015-11-23 3 2022-11-11
PubMed 31610337 No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis. BACKGROUND & AIMS: Ulcerative proctitis (UP) refracto 2.17 KB 2022-05-31 2 2022-11-11
PubMed 31780764 Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis. While immunomodulators (IMs) are used as key drugs in remission maintenance 2.21 KB 2022-11-11 12 2022-11-11
PubMed 24596646 A case of ulcerative colitis presenting as pyoderma gangrenosum and lung nodule. Pyoderma gangrenosum is a phenomenon of cutaneous ulceration where etiology is not well understood. About half of the c 528 Bytes 2016-01-15 4 2022-11-11
PubMed 18729845 A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis. BACKGROUND: Infliximab (IFX) has been shown to be efficacious 1.69 KB 2022-11-11 1 2022-11-11